Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism
Breakthrough Therapy Designation granted based on key positive data from the Phase 2b (RIZE) study and current unmet medical need in congenital hyperinsulinism (HI) Ersodetug continues to advance in ...
Daily2d
Continuous Glucose Monitoring Improves Glycemic Control and Reduces Clinical Events in Type 1 and Type 2 Diabetes: Study
USA: Using continuous glucose monitoring (CGM) can significantly reduce mortality risk in individuals with type 1 and type 2 ...
Healthshots on MSN3d
Brittle diabetes makes blood sugar management hard: Know all about it
If you have diabetes, you must be doing everything to manage it. You may be following a healthy diet with no sugar, taking ...